Effectiveness of bezafibrate and ursodeoxycholic acid in patients with primary biliary cholangitis: a meta-analysis of randomized controlled trials

BACKGROUND: Ursodeoxycholic acid (UDCA) and obeticholic acid are currently approved treatments for primary biliary cholangitis (PBC). Since some patients do not respond adequately to UDCA, other therapies, such as bezafibrate, have been developed. In this meta-analysis we evaluated the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Rohit, Majeed, Muhammad, Attar, Bashar M., Omar, Yazan Abu, Mbachi, Chimezie, Wang, Yanting, Flores, Estefania, Shaqib, Shami, Wang, Yuchen, Udechukwu, Victor, Demetria, Melchor, Gandhi, Seema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686091/
https://www.ncbi.nlm.nih.gov/pubmed/31474796
http://dx.doi.org/10.20524/aog.2019.0403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686091/
https://www.ncbi.nlm.nih.gov/pubmed/31474796
http://dx.doi.org/10.20524/aog.2019.0403

Ejemplares similares